Related Experiment Video
Updated: Jul 16, 2026

Patch Clamp Recordings on Intact Dorsal Root Ganglia from Adult Rats
Published on: September 29, 2016
Rapid modulation of micro-opioid receptor signaling in primary sensory neurons
Kelly A Berg1, Amol M Patwardhan, Teresa A Sanchez
1Department of Pharmacology, MS 7764, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Abstract:
Management of pain by opioid analgesics is confounded by central adverse effects that limit clinical dosages. Consequently, there is considerable interest to understand peripheral analgesic effects of opioids. The actions of opioids on peripheral sensory neurons have been difficult to study because of a general lack of effect of opioid agonists on nociceptor function in culture despite documented presence of opioid receptors. In this study, the micro-opioid receptor agonist, [D-Ala(2),N-MePhe(4),Gly-ol(5)]-enkephalin (DAMGO), did not alter guanosine 5'-O-(3-[(35)S]thio)-triphosphate (GTPgamma[(35)S]) binding, adenylyl cyclase activity, or neuropeptide release in primary cultures of rat trigeminal ganglion (TG). However, after brief exposure to bradykinin (BK), DAMGO stimulated GTPgamma[(35)S] binding and inhibited both prostaglandin E(2) (PGE(2))-stimulated adenylyl cyclase activity and BK/PGE(2)-stimulated neuropeptide release. The effect of BK was blocked by the B(2) antagonist HOE 140 [D-Arg[Hyp(3),Thi(5),D-Tic(7),Oic(8)]-bradykinin], but not by the B(1) antagonist, Lys-[Leu8]des-Arg9-BK, and was mimicked by the protease-activated receptor-2 agonist, Ser-Leu-Ile-Gly-Arg-Leu-NH(2), and by activation of protein kinase C (PKC) or by administration of arachidonic acid (AA). The enhanced responsiveness of micro-opioid receptor signaling by BK priming was blocked by both cyclooxygenase and PKC inhibitors; however, the effect of AA was blocked only by a cyclooxygenase inhibitor. The results indicate that micro-opioid receptor signaling in primary sensory TG neurons is enhanced by activation of phospholipase C-coupled receptors via a cyclooxygenase-dependent AA metabolite that is downstream of PKC.
Insights
Peripheral opioid analgesics show limited effects due to central side effects. This study reveals bradykinin priming enhances micro-opioid receptor signaling in sensory neurons via a cyclooxygenase-dependent pathway.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Management
Background:
- Opioid analgesics are limited by central adverse effects, necessitating research into peripheral actions.
- Understanding peripheral opioid effects on sensory neurons is crucial for pain management.
- Opioid agonists typically show minimal effects on cultured nociceptors despite receptor presence.
Purpose of the Study:
- To investigate the mechanisms underlying opioid receptor signaling in peripheral sensory neurons.
- To explore how bradykinin (BK) influences micro-opioid receptor (MOR) agonist activity.
- To elucidate the signaling pathways involved in enhanced MOR responsiveness.
Main Methods:
- Primary cultures of rat trigeminal ganglion (TG) neurons were used.
- Micro-opioid receptor agonist [D-Ala(2),N-MePhe(4),Gly-ol(5)]-enkephalin (DAMGO) was applied.
- Guanosine 5'-O-(3-[(35)S]thio)-triphosphate (GTPγ[35S]) binding, adenylyl cyclase activity, and neuropeptide release were measured.
- Effects of bradykinin (BK), receptor antagonists, and signaling pathway activators/inhibitors were assessed.
Main Results:
- DAMGO alone did not affect basal GTPγ[35S] binding, adenylyl cyclase, or neuropeptide release.
- Brief BK exposure potentiated DAMGO-stimulated GTPγ[35S] binding.
- BK priming inhibited prostaglandin E(2) (PGE(2))-stimulated adenylyl cyclase and BK/PGE(2)-stimulated neuropeptide release.
- BK's effects involved B(2) receptors, protein kinase C (PKC), and cyclooxygenase (COX) dependent arachidonic acid (AA) metabolites.
Conclusions:
- Micro-opioid receptor signaling in TG neurons is enhanced by BK priming.
- This enhancement is mediated by a COX-dependent AA metabolite downstream of PKC.
- Findings suggest novel pathways for modulating peripheral opioid efficacy in pain relief.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
GPCR Desensitization
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Nociception
